3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
11
Observational
1
Sponsor
Cancer Type
Breast
10
Tumor-Agnostic
1
Classical hematology
1
Conditions
Neoplasm Metastasis
1
Interventions
Surveys and Questionnaires
48
Blood Specimen Collection
22
Interviews as Topic
14
Data Collection
11
Magnetic Resonance Spectroscopy
6
Hematologic Tests
6
Specimen Handling
5
Restraint, Physical
5
Radiotherapy
5
Palliative Care
4
Observation
4
Mental Status and Dementia Tests
4
Watchful Waiting
3
Registries
3
Quality of Life
3
Phlebotomy
3
Neoadjuvant Therapy
3
Magnetic Resonance Imaging
3
Lapatinib
3
Immunotherapy
3
Immune Checkpoint Inhibitors
3
Health Records, Personal
3
Focus Groups
3
Drug Therapy
3
Bevacizumab
3
Absorptiometry, Photon
3
veliparib
2
talazoparib
2
rucaparib
2
pamiparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
abemaciclib
×
Tumor-Agnostic
×
Clear all
NCT05789771
2023-03-31
ATLANT
Blokhin's Russian Cancer Research Center
Completed
136 enrolled